Journal
CIRCULATION
Volume 134, Issue 18, Pages E367-E386Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIR.0000000000000444
Keywords
AHA Scientific Statements; cardiovascular disease; hypertension; insomnia; obesity; obstructive sleep apnea; sleep; type 2 diabetes
Ask authors/readers for more resources
Sleep is increasingly recognized as an important lifestyle contributor to health. However, this has not always been the case, and an increasing number of Americans choose to curtail sleep in favor of other social, leisure, or work-related activities. This has resulted in a decline in average sleep duration over time. Sleep duration, mostly short sleep, and sleep disorders have emerged as being related to adverse cardiometabolic risk, including obesity, hypertension, type 2 diabetes mellitus, and cardiovascular disease. Here, we review the evidence relating sleep duration and sleep disorders to cardiometabolic risk and call for health organizations to include evidence-based sleep recommendations in their guidelines for optimal health.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available